ProShare Advisors
SCLN

ProShare Advisors’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History

ProShare Advisors’s Portfolio SCLN Stock Details SCLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-37,435
Closed -$384K – 1770
2016
Q3 		$384K Sell
37,435
-6,963
-16% -$75.8K 0.01% 1057
2016
Q2 		$580K Buy
44,398
+1,784
+4% +$23.4K 0.01% 906
2016
Q1 		$469K Sell
42,614
-4,314
-9% -$38.4K 0.01% 1027
2015
Q4 		$432K Buy
46,928
+3,869
+9% +$32.4K 0.01% 1110
2015
Q3 		$299K Sell
43,059
-2,831
-6% -$24.2K ﹤0.01% 1148
2015
Q2 		$451K Sell
45,890
-4,966
-10% -$45.2K 0.01% 1137
2015
Q1 		$451K Buy
50,856
+6,256
+14% +$49.8K 0.01% 1234
2014
Q4 		$391K Sell
44,600
-2,082
-4% -$16.9K ﹤0.01% 1344
2014
Q3 		$322K Sell
46,682
-9,557
-17% -$57.3K ﹤0.01% 1672
2014
Q2 		$296K Sell
56,239
-39,162
-41% -$191K ﹤0.01% 1922
2014
Q1 		$434K Buy
95,401
+68,020
+248% +$329K 0.01% 1981
2013
Q4 		$138K Sell
27,381
-25,908
-49% -$125K ﹤0.01% 1285
2013
Q3 		$270K Buy
53,289
+6,008
+13% +$33.5K 0.01% 1971
2013
Q2 		$235K Buy
+47,281
New +$225K ﹤0.01% 1910

Other funds holding SCLN

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return

ProShare Advisors's SCLN Position: Q4 2016 in Review

ProShare Advisors sold out of Sciclone Pharmaceuticals Inc (SCLN) in Q4 2016, closing a stake of 37,435 shares — an estimated $384K sold.

ProShare Advisors first reported a position in SCLN in Q2 2013 and held it in 14 quarters. The position peaked at $580K in Q2 2016. 153 funds tracked by Wall St. Rank hold SCLN as of Q4 2016.

  • ProShare Advisors reported no remaining Sciclone Pharmaceuticals Inc position as of Q4 2016 after selling out during the quarter.
  • ProShare Advisors sold 37,435 Sciclone Pharmaceuticals Inc shares in Q4 2016, an estimated $384K.
  • ProShare Advisors first reported a position in Sciclone Pharmaceuticals Inc in Q2 2013 and held it in 14 quarters.
  • ProShare Advisors's Sciclone Pharmaceuticals Inc position peaked at $580K in Q2 2016.
  • 153 funds tracked by Wall St. Rank held Sciclone Pharmaceuticals Inc as of Q4 2016.

Based on ProShare Advisors's 13F filing for Q4 2016, filed 13 Feb 2017.